Industry Research Reports

Home > Reports > Pharma & Healthcare > Global Rho(D) Immune Globulin Market Research Report 2024

Global Rho(D) Immune Globulin Market Research Report 2024

Industry: Pharma & Healthcare

Published Date: 2024-01-17

Pages: 81 Pages

Report ld: 2302189

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Rho(D) immune globulin (RhIG) is a medication used to prevent Rh isoimmunization in mothers who are Rh negative and to treat idiopathic thrombocytopenic purpura (ITP) in people who are Rh positive. It is often given both during and following pregnancy. It may also be used when Rh negative people are given Rh positive blood. It is given by injection into muscle or a vein. A single dose lasts 2 to 4 weeks.

The global Rho(D) Immune Globulin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

Rho(D) Immune Globulin, also known as anti-Rh factor immunoglobulin, is a biological product used to prevent Rh hemolytic disease of the newborn in cases where an Rh-negative mother is carrying an Rh-positive fetus. In the market, driven by advancements in medical technology and awareness, there is a steady growth in demand for Rho(D) immune globulin. Currently, the product finds extensive application in the fields of prenatal care and obstetrics, particularly in high-risk pregnancies to prevent Rh hemolytic disease. With ongoing advancements in biologic manufacturing techniques, the future development of Rho(D) immune globulin might focus on refinement to enhance efficacy and reduce side effects, catering to the continually expanding market needs.

This report aims to provide a comprehensive presentation of the global market for Rho(D) Immune Globulin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rho(D) Immune Globulin.

MARKET SEGMENTATION

By Company

CSL Behring
Grіfоlѕ
Bayer
Kedrion Biopharma
Saol Therapeutics

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

5 ml
10 ml

Segment by Application

Government Institution
Private Sector
Others

biaoTi REPORT SCOPE

The Rho(D) Immune Globulin market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Rho(D) Immune Globulin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Rho(D) Immune Globulin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Rho(D) Immune Globulin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Rho(D) Immune Globulin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Rho(D) Immune Globulin Market Overview

1.1 Product Overview and Scope of Rho(D) Immune Globulin

1.2 Rho(D) Immune Globulin Segment by Type

1.2.1 Global Rho(D) Immune Globulin Market Value Comparison by Type (2024-2030)

1.2.2 5 ml

1.2.3 10 ml

1.3 Rho(D) Immune Globulin Segment by Application

1.3.1 Global Rho(D) Immune Globulin Market Value by Application: (2024-2030)

1.3.2 Government Institution

1.3.3 Private Sector

1.3.4 Others

1.4 Global Rho(D) Immune Globulin Market Size Estimates and Forecasts

1.4.1 Global Rho(D) Immune Globulin Revenue 2019-2030

1.4.2 Global Rho(D) Immune Globulin Sales 2019-2030

1.4.3 Global Rho(D) Immune Globulin Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Rho(D) Immune Globulin Market Competition by Manufacturers

2.1 Global Rho(D) Immune Globulin Sales Market Share by Manufacturers (2019-2024)

2.2 Global Rho(D) Immune Globulin Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Rho(D) Immune Globulin Average Price by Manufacturers (2019-2024)

2.4 Global Rho(D) Immune Globulin Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Rho(D) Immune Globulin, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Rho(D) Immune Globulin, Product Type & Application

2.7 Rho(D) Immune Globulin Market Competitive Situation and Trends

2.7.1 Rho(D) Immune Globulin Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Rho(D) Immune Globulin Players Market Share by Revenue

2.7.3 Global Rho(D) Immune Globulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Rho(D) Immune Globulin Retrospective Market Scenario by Region

3.1 Global Rho(D) Immune Globulin Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Rho(D) Immune Globulin Global Rho(D) Immune Globulin Sales by Region: 2019-2030

3.2.1 Global Rho(D) Immune Globulin Sales by Region: 2019-2024

3.2.2 Global Rho(D) Immune Globulin Sales by Region: 2025-2030

3.3 Global Rho(D) Immune Globulin Global Rho(D) Immune Globulin Revenue by Region: 2019-2030

3.3.1 Global Rho(D) Immune Globulin Revenue by Region: 2019-2024

3.3.2 Global Rho(D) Immune Globulin Revenue by Region: 2025-2030

3.4 North America Rho(D) Immune Globulin Market Facts & Figures by Country

3.4.1 North America Rho(D) Immune Globulin Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Rho(D) Immune Globulin Sales by Country (2019-2030)

3.4.3 North America Rho(D) Immune Globulin Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Rho(D) Immune Globulin Market Facts & Figures by Country

3.5.1 Europe Rho(D) Immune Globulin Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Rho(D) Immune Globulin Sales by Country (2019-2030)

3.5.3 Europe Rho(D) Immune Globulin Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Rho(D) Immune Globulin Market Facts & Figures by Country

3.6.1 Asia Pacific Rho(D) Immune Globulin Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Rho(D) Immune Globulin Sales by Country (2019-2030)

3.6.3 Asia Pacific Rho(D) Immune Globulin Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Rho(D) Immune Globulin Market Facts & Figures by Country

3.7.1 Latin America Rho(D) Immune Globulin Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Rho(D) Immune Globulin Sales by Country (2019-2030)

3.7.3 Latin America Rho(D) Immune Globulin Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Rho(D) Immune Globulin Market Facts & Figures by Country

3.8.1 Middle East and Africa Rho(D) Immune Globulin Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Rho(D) Immune Globulin Sales by Country (2019-2030)

3.8.3 Middle East and Africa Rho(D) Immune Globulin Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Rho(D) Immune Globulin Sales by Type (2019-2030)

4.1.1 Global Rho(D) Immune Globulin Sales by Type (2019-2024)

4.1.2 Global Rho(D) Immune Globulin Sales by Type (2025-2030)

4.1.3 Global Rho(D) Immune Globulin Sales Market Share by Type (2019-2030)

4.2 Global Rho(D) Immune Globulin Revenue by Type (2019-2030)

4.2.1 Global Rho(D) Immune Globulin Revenue by Type (2019-2024)

4.2.2 Global Rho(D) Immune Globulin Revenue by Type (2025-2030)

4.2.3 Global Rho(D) Immune Globulin Revenue Market Share by Type (2019-2030)

4.3 Global Rho(D) Immune Globulin Price by Type (2019-2030)

5 Segment by Application

5.1 Global Rho(D) Immune Globulin Sales by Application (2019-2030)

5.1.1 Global Rho(D) Immune Globulin Sales by Application (2019-2024)

5.1.2 Global Rho(D) Immune Globulin Sales by Application (2025-2030)

5.1.3 Global Rho(D) Immune Globulin Sales Market Share by Application (2019-2030)

5.2 Global Rho(D) Immune Globulin Revenue by Application (2019-2030)

5.2.1 Global Rho(D) Immune Globulin Revenue by Application (2019-2024)

5.2.2 Global Rho(D) Immune Globulin Revenue by Application (2025-2030)

5.2.3 Global Rho(D) Immune Globulin Revenue Market Share by Application (2019-2030)

5.3 Global Rho(D) Immune Globulin Price by Application (2019-2030)

6 Key Companies Profiled

6.1 CSL Behring

6.1.1 CSL Behring Corporation Information

6.1.2 CSL Behring Description and Business Overview

6.1.3 CSL Behring Rho(D) Immune Globulin Sales, Revenue and Gross Margin (2019-2024)

6.1.4 CSL Behring Rho(D) Immune Globulin Product Portfolio

6.1.5 CSL Behring Recent Developments/Updates

6.2 Grіfоlѕ

6.2.1 Grіfоlѕ Corporation Information

6.2.2 Grіfоlѕ Description and Business Overview

6.2.3 Grіfоlѕ Rho(D) Immune Globulin Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Grіfоlѕ Rho(D) Immune Globulin Product Portfolio

6.2.5 Grіfоlѕ Recent Developments/Updates

6.3 Bayer

6.3.1 Bayer Corporation Information

6.3.2 Bayer Description and Business Overview

6.3.3 Bayer Rho(D) Immune Globulin Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Bayer Rho(D) Immune Globulin Product Portfolio

6.3.5 Bayer Recent Developments/Updates

6.4 Kedrion Biopharma

6.4.1 Kedrion Biopharma Corporation Information

6.4.2 Kedrion Biopharma Description and Business Overview

6.4.3 Kedrion Biopharma Rho(D) Immune Globulin Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Kedrion Biopharma Rho(D) Immune Globulin Product Portfolio

6.4.5 Kedrion Biopharma Recent Developments/Updates

6.5 Saol Therapeutics

6.5.1 Saol Therapeutics Corporation Information

6.5.2 Saol Therapeutics Description and Business Overview

6.5.3 Saol Therapeutics Rho(D) Immune Globulin Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Saol Therapeutics Rho(D) Immune Globulin Product Portfolio

6.5.5 Saol Therapeutics Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Rho(D) Immune Globulin Industry Chain Analysis

7.2 Rho(D) Immune Globulin Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Rho(D) Immune Globulin Production Mode & Process

7.4 Rho(D) Immune Globulin Sales and Marketing

7.4.1 Rho(D) Immune Globulin Sales Channels

7.4.2 Rho(D) Immune Globulin Distributors

7.5 Rho(D) Immune Globulin Customers

8 Rho(D) Immune Globulin Market Dynamics

8.1 Rho(D) Immune Globulin Industry Trends

8.2 Rho(D) Immune Globulin Market Drivers

8.3 Rho(D) Immune Globulin Market Challenges

8.4 Rho(D) Immune Globulin Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Rho(D) Immune Globulin Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Rho(D) Immune Globulin Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Rho(D) Immune Globulin Market Competitive Situation by Manufacturers in 2023

Table 4. Global Rho(D) Immune Globulin Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Rho(D) Immune Globulin Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Rho(D) Immune Globulin Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Rho(D) Immune Globulin Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Rho(D) Immune Globulin Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Rho(D) Immune Globulin, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Rho(D) Immune Globulin, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Rho(D) Immune Globulin, Product Type & Application

Table 12. Global Key Manufacturers of Rho(D) Immune Globulin, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Rho(D) Immune Globulin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rho(D) Immune Globulin as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Rho(D) Immune Globulin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Rho(D) Immune Globulin Sales by Region (2019-2024) & (K Units)

Table 18. Global Rho(D) Immune Globulin Sales Market Share by Region (2019-2024)

Table 19. Global Rho(D) Immune Globulin Sales by Region (2025-2030) & (K Units)

Table 20. Global Rho(D) Immune Globulin Sales Market Share by Region (2025-2030)

Table 21. Global Rho(D) Immune Globulin Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Rho(D) Immune Globulin Revenue Market Share by Region (2019-2024)

Table 23. Global Rho(D) Immune Globulin Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Rho(D) Immune Globulin Revenue Market Share by Region (2025-2030)

Table 25. North America Rho(D) Immune Globulin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Rho(D) Immune Globulin Sales by Country (2019-2024) & (K Units)

Table 27. North America Rho(D) Immune Globulin Sales by Country (2025-2030) & (K Units)

Table 28. North America Rho(D) Immune Globulin Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Rho(D) Immune Globulin Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Rho(D) Immune Globulin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Rho(D) Immune Globulin Sales by Country (2019-2024) & (K Units)

Table 32. Europe Rho(D) Immune Globulin Sales by Country (2025-2030) & (K Units)

Table 33. Europe Rho(D) Immune Globulin Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Rho(D) Immune Globulin Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Rho(D) Immune Globulin Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Rho(D) Immune Globulin Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Rho(D) Immune Globulin Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Rho(D) Immune Globulin Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Rho(D) Immune Globulin Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Rho(D) Immune Globulin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Rho(D) Immune Globulin Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Rho(D) Immune Globulin Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Rho(D) Immune Globulin Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Rho(D) Immune Globulin Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Rho(D) Immune Globulin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Rho(D) Immune Globulin Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Rho(D) Immune Globulin Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Rho(D) Immune Globulin Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Rho(D) Immune Globulin Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Rho(D) Immune Globulin Sales (K Units) by Type (2019-2024)

Table 51. Global Rho(D) Immune Globulin Sales (K Units) by Type (2025-2030)

Table 52. Global Rho(D) Immune Globulin Sales Market Share by Type (2019-2024)

Table 53. Global Rho(D) Immune Globulin Sales Market Share by Type (2025-2030)

Table 54. Global Rho(D) Immune Globulin Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Rho(D) Immune Globulin Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Rho(D) Immune Globulin Revenue Market Share by Type (2019-2024)

Table 57. Global Rho(D) Immune Globulin Revenue Market Share by Type (2025-2030)

Table 58. Global Rho(D) Immune Globulin Price (US$/Unit) by Type (2019-2024)

Table 59. Global Rho(D) Immune Globulin Price (US$/Unit) by Type (2025-2030)

Table 60. Global Rho(D) Immune Globulin Sales (K Units) by Application (2019-2024)

Table 61. Global Rho(D) Immune Globulin Sales (K Units) by Application (2025-2030)

Table 62. Global Rho(D) Immune Globulin Sales Market Share by Application (2019-2024)

Table 63. Global Rho(D) Immune Globulin Sales Market Share by Application (2025-2030)

Table 64. Global Rho(D) Immune Globulin Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Rho(D) Immune Globulin Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Rho(D) Immune Globulin Revenue Market Share by Application (2019-2024)

Table 67. Global Rho(D) Immune Globulin Revenue Market Share by Application (2025-2030)

Table 68. Global Rho(D) Immune Globulin Price (US$/Unit) by Application (2019-2024)

Table 69. Global Rho(D) Immune Globulin Price (US$/Unit) by Application (2025-2030)

Table 70. CSL Behring Corporation Information

Table 71. CSL Behring Description and Business Overview

Table 72. CSL Behring Rho(D) Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. CSL Behring Rho(D) Immune Globulin Product

Table 74. CSL Behring Recent Developments/Updates

Table 75. Grіfоlѕ Corporation Information

Table 76. Grіfоlѕ Description and Business Overview

Table 77. Grіfоlѕ Rho(D) Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Grіfоlѕ Rho(D) Immune Globulin Product

Table 79. Grіfоlѕ Recent Developments/Updates

Table 80. Bayer Corporation Information

Table 81. Bayer Description and Business Overview

Table 82. Bayer Rho(D) Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Bayer Rho(D) Immune Globulin Product

Table 84. Bayer Recent Developments/Updates

Table 85. Kedrion Biopharma Corporation Information

Table 86. Kedrion Biopharma Description and Business Overview

Table 87. Kedrion Biopharma Rho(D) Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Kedrion Biopharma Rho(D) Immune Globulin Product

Table 89. Kedrion Biopharma Recent Developments/Updates

Table 90. Saol Therapeutics Corporation Information

Table 91. Saol Therapeutics Description and Business Overview

Table 92. Saol Therapeutics Rho(D) Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Saol Therapeutics Rho(D) Immune Globulin Product

Table 94. Saol Therapeutics Recent Developments/Updates

Table 95. Key Raw Materials Lists

Table 96. Raw Materials Key Suppliers Lists

Table 97. Rho(D) Immune Globulin Distributors List

Table 98. Rho(D) Immune Globulin Customers List

Table 99. Rho(D) Immune Globulin Market Trends

Table 100. Rho(D) Immune Globulin Market Drivers

Table 101. Rho(D) Immune Globulin Market Challenges

Table 102. Rho(D) Immune Globulin Market Restraints

Table 103. Research Programs/Design for This Report

Table 104. Key Data Information from Secondary Sources

Table 105. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Rho(D) Immune Globulin

Figure 2. Global Rho(D) Immune Globulin Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Rho(D) Immune Globulin Market Share by Type in 2023 & 2030

Figure 4. 5 ml Product Picture

Figure 5. 10 ml Product Picture

Figure 6. Global Rho(D) Immune Globulin Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Rho(D) Immune Globulin Market Share by Application in 2023 & 2030

Figure 8. Government Institution

Figure 9. Private Sector

Figure 10. Others

Figure 11. Global Rho(D) Immune Globulin Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Rho(D) Immune Globulin Market Size (2019-2030) & (US$ Million)

Figure 13. Global Rho(D) Immune Globulin Sales (2019-2030) & (K Units)

Figure 14. Global Rho(D) Immune Globulin Average Price (US$/Unit) & (2019-2030)

Figure 15. Rho(D) Immune Globulin Report Years Considered

Figure 16. Rho(D) Immune Globulin Sales Share by Manufacturers in 2023

Figure 17. Global Rho(D) Immune Globulin Revenue Share by Manufacturers in 2023

Figure 18. The Global 5 and 10 Largest Rho(D) Immune Globulin Players: Market Share by Revenue in 2023

Figure 19. Rho(D) Immune Globulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 20. Global Rho(D) Immune Globulin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 21. North America Rho(D) Immune Globulin Sales Market Share by Country (2019-2030)

Figure 22. North America Rho(D) Immune Globulin Revenue Market Share by Country (2019-2030)

Figure 23. U.S. Rho(D) Immune Globulin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Canada Rho(D) Immune Globulin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Europe Rho(D) Immune Globulin Sales Market Share by Country (2019-2030)

Figure 26. Europe Rho(D) Immune Globulin Revenue Market Share by Country (2019-2030)

Figure 27. Germany Rho(D) Immune Globulin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. France Rho(D) Immune Globulin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. U.K. Rho(D) Immune Globulin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Italy Rho(D) Immune Globulin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Russia Rho(D) Immune Globulin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Asia Pacific Rho(D) Immune Globulin Sales Market Share by Region (2019-2030)

Figure 33. Asia Pacific Rho(D) Immune Globulin Revenue Market Share by Region (2019-2030)

Figure 34. China Rho(D) Immune Globulin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Japan Rho(D) Immune Globulin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. South Korea Rho(D) Immune Globulin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. India Rho(D) Immune Globulin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Australia Rho(D) Immune Globulin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Taiwan Rho(D) Immune Globulin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Indonesia Rho(D) Immune Globulin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Thailand Rho(D) Immune Globulin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Malaysia Rho(D) Immune Globulin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Philippines Rho(D) Immune Globulin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Latin America Rho(D) Immune Globulin Sales Market Share by Country (2019-2030)

Figure 45. Latin America Rho(D) Immune Globulin Revenue Market Share by Country (2019-2030)

Figure 46. Mexico Rho(D) Immune Globulin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Brazil Rho(D) Immune Globulin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Argentina Rho(D) Immune Globulin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Middle East & Africa Rho(D) Immune Globulin Sales Market Share by Country (2019-2030)

Figure 50. Middle East & Africa Rho(D) Immune Globulin Revenue Market Share by Country (2019-2030)

Figure 51. Turkey Rho(D) Immune Globulin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Saudi Arabia Rho(D) Immune Globulin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. U.A.E Rho(D) Immune Globulin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Global Sales Market Share of Rho(D) Immune Globulin by Type (2019-2030)

Figure 55. Global Revenue Market Share of Rho(D) Immune Globulin by Type (2019-2030)

Figure 56. Global Rho(D) Immune Globulin Price (US$/Unit) by Type (2019-2030)

Figure 57. Global Sales Market Share of Rho(D) Immune Globulin by Application (2019-2030)

Figure 58. Global Revenue Market Share of Rho(D) Immune Globulin by Application (2019-2030)

Figure 59. Global Rho(D) Immune Globulin Price (US$/Unit) by Application (2019-2030)

Figure 60. Rho(D) Immune Globulin Value Chain

Figure 61. Rho(D) Immune Globulin Production Process

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Distributors Profiles

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Rho(D) Immune Globulin market? zhanKai

The top companies in the global Rho(D) Immune Globulin market are CSL Behring、Grіfоlѕ、Bayer.

Related Reports

Global Rho(D) Immune Globulin Market Research Report 2025
The global market for Rho(D) Immune Globulin was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-01
Pages: 76
USD 2900.00
(Single User License)
Global Rho(D) Immune Globulin Market Insights, Forecast to 2030
Rho(D) immune globulin (RhIG) is a medication used to prevent Rh isoimmunization in mothers who are Rh negative and to treat idiopathic thrombocytopenic purpura (ITP) in people who are Rh positive. It is often given both during and following pregnancy. It may also be used when Rh negative people are given Rh positive blood. It is given by injection into muscle or a vein. A single dose lasts 2 to 4 weeks.
Published Date: 2024-04-12
Pages: 90
USD 4900.00
(Single User License)
Rho(D) Immune Globulin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Rho(D) immune globulin (RhIG) is a medication used to prevent Rh isoimmunization in mothers who are Rh negative and to treat idiopathic thrombocytopenic purpura (ITP) in people who are Rh positive. It is often given both during and following pregnancy. It may also be used when Rh negative people are given Rh positive blood. It is given by injection into muscle or a vein. A single dose lasts 2 to 4 weeks.
Published Date: 2024-01-10
Pages: 99
USD 3950.00
(Single User License)

Global Rho(D) Immune Globulin Market Research Report 2025
The global market for Rho(D) Immune Globulin was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-01
Pages: 76
USD 2900.00 (Single User License)
Global Rho(D) Immune Globulin Market Insights, Forecast to 2030
Rho(D) immune globulin (RhIG) is a medication used to prevent Rh isoimmunization in mothers who are Rh negative and to treat idiopathic thrombocytopenic purpura (ITP) in people who are Rh positive. It is often given both during and following pregnancy. It may also be used when Rh negative people are given Rh positive blood. It is given by injection into muscle or a vein. A single dose lasts 2 to 4 weeks.
Published: 2024-04-12
Pages: 90
USD 4900.00 (Single User License)
Rho(D) Immune Globulin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Rho(D) immune globulin (RhIG) is a medication used to prevent Rh isoimmunization in mothers who are Rh negative and to treat idiopathic thrombocytopenic purpura (ITP) in people who are Rh positive. It is often given both during and following pregnancy. It may also be used when Rh negative people are given Rh positive blood. It is given by injection into muscle or a vein. A single dose lasts 2 to 4 weeks.
Published: 2024-01-10
Pages: 99
USD 3950.00 (Single User License)